Financial Partners Group, Inc Pfizer Inc Transaction History

Financial Partners Group, Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	BUY	$36.12 - $41.79 $4,442 - $5,140	123 Added 2.01%	6,240 $228,000
Q1 2023 May 12, 2023	BUY	$39.39 - $51.28 $8,193 - $10,666	208 Added 3.52%	6,117 $249,000
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $44,129 - $57,606	-1,057 Reduced 15.17%	5,909 $302,000
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $32,076 - $39,156	-733 Reduced 9.52%	6,966 $305,000
Q2 2022 Aug 12, 2022	SELL	$46.53 - $55.17 $34,153 - $40,494	-734 Reduced 8.7%	7,699 $404,000
Q1 2022 Apr 29, 2022	BUY	$45.75 - $56.69 $1,006 - $1,247	22 Added 0.26%	8,433 $437,000
Q4 2021 Feb 10, 2022	BUY	$41.32 - $61.25 $38,551 - $57,146	933 Added 12.48%	8,411 $443,000
Q3 2021 Nov 05, 2021	BUY	$39.25 - $50.42 $549 - $705	14 Added 0.19%	7,478 $322,000
Q2 2021 Aug 13, 2021	BUY	$35.91 - $40.68 $268,032 - $303,635	7,464 New	7,464 $292,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Financial Partners Group, Inc, based on Form 13F filings with the SEC.

Stay updated on Financial Partners Group, Inc with notifications on news.